ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Crispr Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Crispr Therapeutics, INC. (Crispr Therapeutics 401(k) Retirement Plan · EIN 47-3173478 · PN 001): $66.70M net assets, 398 active participants, and Sponsor-paid or unbenchmarked.

Reported Form 5500 Fee & Service Summary

Plan SponsorCrispr Therapeutics, INC.
Filing IdentifierCrispr Therapeutics 401(k) Retirement Plan · EIN 47-3173478 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$66.70M
Active Participants398
Direct Admin Fee RateSponsor-paid or unbenchmarked
Cohort Peer MedianN/A
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI